Empaa Tablets 25mg

Medicine Name: Empaa Tablets 25mg

Empaa Tablets Specification
Requires Prescription:
Yes
________________________________________
Generic Name:
Empagliflozin
________________________________________
Used For:
Type 2 Diabetes Mellitus
To improve blood glucose control in adults
As monotherapy or add-on therapy with other antidiabetic agents (e.g., insulin)
________________________________________
How It Works:
Empagliflozin is a SGLT2 inhibitor (Sodium-Glucose Co-Transporter 2 inhibitor).
It works in the kidneys to prevent glucose reabsorption into the blood.
This leads to increased urinary glucose excretion, thereby reducing blood sugar levels.
________________________________________
Empaa Tablets Usage and Safety
Dosage:
Empagliflozin
Dose depends on the patient's condition, renal function, and treatment goals.
Typically taken once daily, with or without food.
________________________________________
Side Effects:
Very Common:
Hypoglycemia (especially when combined with sulfonylureas or insulin)
Common:
Genital infections (vaginal moniliasis, vulvovaginitis, balanitis)
Urinary tract infections (UTIs)
Increased urination
Generalized itching (pruritus)
Uncommon:
Volume depletion (dehydration)
Painful urination (dysuria)
Increased blood creatinine or decreased glomerular filtration rate
Rare:
Diabetic ketoacidosis (DKA)
________________________________________
Drug Interactions:
Diuretics (especially thiazide or loop): May increase risk of hypotension or dehydration
Other SGLT2 inhibitors: Should not be used in combination
Caution when used with insulin or insulin secretagogues (e.g., sulfonylureas) due to hypoglycemia risk
________________________________________
Indications:
Empagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus:
Monotherapy: In patients who cannot tolerate metformin
Add-on therapy: In combination with other antidiabetic agents when glycemic control is not adequate
________________________________________
When Not to Use:
Known hypersensitivity to empagliflozin or any excipients
Severe renal impairment, end-stage renal disease (ESRD), or patients on dialysis
________________________________________
Empaa Tablets Precautions & Warnings
Precautions:
Risk of hypotension due to volume loss, especially in elderly, renally impaired, or diuretic users
Monitor renal function periodically
Ensure proper hydration to avoid dehydration-related complications
________________________________________
Warnings:
1. Risk of Hypoglycemia:
Higher risk when used with insulin or sulfonylureas
Consider lowering the dose of insulin or secretagogue
2. Increased Risk of UTIs:
Can cause serious urinary tract infections (e.g., pyelonephritis, urosepsis)
Discontinue if recurrent UTIs occur
3. Ketoacidosis (DKA):
May occur even in type 2 diabetes patients
Discontinue if ketoacidosis is suspected or confirmed
Avoid in type 1 diabetes
Temporarily stop in cases of major surgery or serious illness
________________________________________
Pregnancy Category:
Use only if clearly needed and under physician supervision.
Discuss risks and benefits with your doctor.
________________________________________

Storage:
Store at room temperature
Keep away from direct light, heat, and moisture
Keep out of reach of children